Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$3.27 - $7.14 $57,725 - $126,042
-17,653 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$1.94 - $3.19 $34,246 - $56,313
17,653 New
17,653 $54,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $96.6M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Hunter Perkins Capital Management, LLC Portfolio

Follow Hunter Perkins Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.